Austrax Holdings Limited Overview
| Field | Detail |
|---|---|
| Current legal name (English) | Austrax Holdings Limited |
| Current dual foreign name (Chinese) | 南強控股有限公司 |
| Former names | Innovax Holdings Limited; 創陞控股有限公司 |
| Effective date of name change | 2 July 2026 (date of the Cayman Islands certificate of incorporation on change of name), approved by special resolution at the EGM of 22 June 2026 |
| Stock short name | Changed from "INNOVAX HLDGS" to "AUSTRAX HLDGS" with effect from Monday, 10 August 2026 (HKEX trading arrangement notice) |
| Website | Changed from www.innovax.hk to www.austrax.com (change-of-name announcement, 4 August 2026) |
| Country of operations | Hong Kong SAR, China |
| Exchange / ticker | Main Board of The Stock Exchange of Hong Kong; stock code 2680 (2680.HK / HKG:2680) |
| ISIN | KYG4790R1092 as supplied. Not re-verified. A 10-to-1 share consolidation took effect on 25 October 2024; consolidations in Hong Kong often carry a new ISIN, so this code should be checked against HKEX/CCASS records |
| CUSIP | Not applicable (no US listing); not publicly disclosed |
The identification details supplied (Innovax Holdings Limited, HKEX 2680, website www.innovax.hk) are outdated. The entity has been renamed.
Core corporate data
| Field | Detail | Source |
|---|---|---|
| Founding year | 2014 (group established in Hong Kong) | Annual Report 2019/20; Annual Report 2025/26 |
| Incorporation jurisdiction | Cayman Islands, exempted company with limited liability | All HKEX filings |
| Registered office | Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands | Annual Report 2025/26 |
| Headquarters and principal place of business in Hong Kong | Rooms 1201–1202 and 1212, 12/F, West Tower, Shun Tak Centre, 168–200 Connaught Road Central, Hong Kong. Address as at the Annual Report date | Annual Report 2025/26 |
| Listing date | 14 September 2018 (Main Board); prospectus dated 31 August 2018 | Annual Report 2025/26 (Deed of Non-competition section) |
| Fiscal year end | Last day of February | All annual reports |
| Shares in issue | 60,000,000 ordinary shares (HK$0.10 par); authorised share capital 100,000,000 shares | Annual Report 2025/26; Monthly Return for September 2026 |
| Controlling shareholder | Mr. Wang Tingfa, through Billion Shine International Investment Limited (BVI), holding 45,000,000 shares (75.00%); plus 39,825 shares (about 0.07%) acquired personally under the mandatory offer | Offer closing announcement, 29 April 2026 |
| Chairman and CEO | Mr. Wang Tingfa (since 30 May 2026) | Change-of-directors announcement, 29 May 2026 |
| Auditor | BDO Limited, Certified Public Accountants (Registered Public Interest Entity Auditor). No auditor change in the past three years | Annual Report 2025/26 |
| Company secretary and CFO | Ms. Chau Lok Yi (company secretary since 4 May 2018; CFO since May 2017) | Annual Report 2025/26; announcement of 7 August 2026 |
| Hong Kong branch share registrar | Union Registrars Limited (from 12 March 2025; previously Computershare Hong Kong Investor Services) | Annual Report 2025/26 |
| Legal advisers | Jingtian & Gongcheng LLP (Hong Kong) | Annual Report 2025/26 |
| Principal bankers | Bank of China (Hong Kong), Chong Hing Bank, Hang Seng Bank, HSBC | Annual Report 2025/26 |
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Employees at year end (incl. executive directors) | 36 | 38 | 38 |
FY2025 and FY2026 come from the Annual Report 2025/26. Female share of workforce at 28 February 2026 was about 34.2%.
Market capitalisation
| Date | Share price (HKD) | Market cap (HKD Mn) | Basis |
|---|---|---|---|
| 9 Oct 2026 (delayed intraday quote) | 5.61 | 336.6 | 60,000,000 shares × price (analyst calculation; price per StockAnalysis.com) |
Austrax Holdings is a micro-cap, Hong Kong-only boutique financial services group. It is licensed by the SFC for Type 1 (dealing in securities), Type 4 (advising on securities), Type 6 (advising on corporate finance) and Type 9 (asset management) regulated activities. Its franchise rests on IPO sponsorship, financial and independent financial advisory, compliance advisory, equity placing and underwriting, retail and corporate brokerage, margin financing and a small but fast-growing asset management arm. Revenue from these activities is small (HK$22.7 M in FY2026) and highly cyclical. Reported earnings are driven mainly by gains and losses on the proprietary investment book rather than by fee income. In 2025–26 the group changed hands: founder Chung Chi Man sold his 75% stake to mainland investor Wang Tingfa for HK$270 M. The money lending and investment-holding subsidiaries were carved out to the founder, the board was replaced, and the group was rebranded as Austrax, with a stated focus on corporate finance advisory for Hong Kong and Greater China clients.
The company's own description (paraphrased from the Annual Report 2025/26)
The Annual Report 2025/26 describes the group as an integrated financial and securities services provider. It holds SFC licences for Type 1, Type 4, Type 6 and Type 9 regulated activities under the Securities and Futures Ordinance (Cap. 571). During FY2026 it also ran a money lending business under the Money Lenders Ordinance (Cap. 163). Its stated service range covers:
-
corporate finance advisory (IPO sponsorship, financial and independent financial advisory, and compliance advisory);
-
placing and underwriting;
-
securities dealing and brokerage;
-
securities financing;
-
research;
-
asset management; and
-
money lending.
The money lending business was reclassified as a discontinued operation after the board approved its sale on 25 September 2025. The sale completed on 31 March 2026.
The rebranding announcement of 29 May 2026 sets out the new owner's intended identity. The board said the Austrax name would give a fresh corporate image and better reflect the group's position as a dedicated local financial institution focused on corporate finance advisory services in Hong Kong and the Greater China region.
Business model and revenue model
The group is a pure services and balance-sheet business. It has no product, subscription or licensing revenue. Its income streams fall into three economic types:
-
Fee-for-mandate advisory revenue (Type 6). This covers IPO sponsorship (milestone-based fees over long project cycles), financial adviser and independent financial adviser (IFA) mandates under the Listing Rules and Takeovers Code, and compliance adviser retainers for newly listed issuers. In FY2026 this stream produced HK$9.9 M from 45 projects (7 IPO sponsorships, 29 FA/IFA mandates, 9 compliance advisory mandates).
-
Transaction-based capital markets revenue (Type 1). This covers placing, underwriting and sub-underwriting commissions on equity placings, IPO distribution and, in FY2025, bond issues. It is highly episodic. It fell from HK$151.5 M in FY2025 to HK$1.8 M in FY2026 after the group stopped bond underwriting. Brokerage commission (HK$5.3 M in FY2026) is also transactional and tracks Hong Kong market turnover.
-
Spread and AUM-based revenue. This covers interest on margin loans and IPO financing (HK$2.0 M in FY2026), asset management and fund management fees (HK$3.7 M in FY2026, on AUM of HK$216.3 M) and, until its disposal, money lending interest (HK$2.4 M in FY2026, reported in discontinued operations).
A fourth, non-revenue earnings stream dominates bottom-line outcomes: realised and unrealised gains or losses on financial assets at fair value through profit or loss (FVTPL). In FY2026 the net realised FVTPL gain was HK$29.1 M and the net unrealised loss was HK$1.8 M. Together these exceeded the year's entire fee revenue (Annual Report 2025/26, MD&A).
Value chain position
The group sits at the small-cap end of the Hong Kong primary-market value chain. It sponsors and distributes IPOs for small and mid-size issuers, advises listed companies and their controllers on notifiable and connected transactions and takeovers, and acts as IFA to independent board committees. It then monetises the same client relationships through post-listing compliance advisory, follow-on placings, brokerage and margin financing. In FY2026 it acted as joint bookrunner and joint lead manager on one IPO. In FY2025 it acted as bookrunner and underwriter on 25 unlisted corporate bond issues.
Much of the FY2025 bond underwriting revenue was passed on to sub-underwriters. Placing and underwriting revenue of HK$151.5 M was offset by HK$148.7 M of sub-underwriting expenses recorded in other operating expenses. The economic margin on that activity was therefore only about HK$2.8 M (analyst calculation from Annual Report 2025/26 figures).
Customer types and end-markets
| Customer type | Services consumed | Evidence |
|---|---|---|
| IPO applicants (Main Board and GEM) | Sponsorship, bookrunning, underwriting, IPO financing for retail subscribers | 7 IPO sponsorship mandates in FY2026 and FY2025; 1 IPO bookrunner role in FY2026 |
| Hong Kong-listed issuers and their controlling shareholders | FA under Listing Rules and Takeovers Code; placing agent for new and existing shares | 21 FA mandates in FY2026 (FY2025: 23); 5 equity placing roles in FY2026 |
| Independent board committees and independent shareholders | IFA opinions | 8 IFA mandates in FY2026 (FY2025: 6) |
| Newly listed issuers | Compliance adviser | 9 mandates in FY2026 |
| Retail and professional investors | Brokerage (HK and US equities), margin finance | 1,296 securities accounts at 28 Feb 2026 (28 Feb 2025: 1,003); margin loans HK$19.3 M |
| Professional investors | Discretionary accounts and funds (via an SFC-registered open-ended fund company and the Innovax Alpha SPC fund) | AUM HK$216.3 M at 28 Feb 2026 (28 Feb 2025: HK$69.2 M) |
| Individuals and corporates (until 31 Mar 2026) | Money lending | 11 personal loans and 2 corporate loans; loan receivables HK$32.6 M |
Customer concentration is moderate. The five largest customers made up about 26.1% of FY2026 revenue and the largest single customer about 6.5% (Annual Report 2025/26). The group reports no major suppliers.
Independent characterisation
On the evidence, Austrax is a sub-scale, sponsor-led boutique and not an "integrated" financial group in any meaningful sense:
-
Recurring fee revenue (advisory plus brokerage plus asset management plus financing interest) was about HK$21 M in FY2026.
-
That sat against staff costs of HK$24.3 M and other operating expenses of HK$17.5 M. The core franchise is therefore loss-making before investment gains (S&P-basis operating income was -HK$20.4 M in FY2026).
-
Over FY2022–FY2026 the group reported a cumulative net loss of about HK$50.9 M (analyst sum of reported net income). Profitable years (FY2024, FY2026) coincided with gains on the proprietary book.
Under a new controller, the investment case now rests on whether the platform's SFC licences, sponsor principal capability and track record can be redeployed into a larger Greater China-oriented corporate finance business. No business plan, targets or capital commitments have been disclosed so far.
Strategy
Stated strategy (Annual Report 2025/26, paraphrased themes)
-
Strengthen the core business by expanding the product range, enhancing services and growing the customer base.
-
Explore diversification through strategic opportunities for long-term development.
-
Prudent, disciplined risk management: enhance risk management and credit control and follow disciplined cost control under complex market conditions.
-
Cross-border alignment: align with national strategies (Greater Bay Area, offshore RMB, listing-regime enhancements) and use the group's overseas network and talent pool for cross-border expansion and strategic partnerships.
-
Equity capital markets: management is optimistic about equity placing and underwriting as IPO sentiment and market liquidity improve.
-
Brokerage and wealth: extend into discretionary account management, wealth management, and US and overseas market brokerage.
-
Asset management: launch multi-strategy and private equity funds through the OFC, Cayman and limited partnership structures.
-
Futures: possible future reapplication for the Type 2 licence.
New-owner strategic signals (May–August 2026)
Rebrand to Austrax: The stated reason is to reposition the group as a dedicated local financial institution focused on corporate finance advisory in Hong Kong and Greater China, align with long-term strategy and strengthen brand presence (announcement of 29 May 2026).
Shrinking to the core: The carve-out of money lending and investment holding to the former owner leaves a narrower, licence-centred platform.
Board reconstituted: with senior Mainland and international banking, accounting and legal profiles. This suggests ambitions for higher-quality mandates, though no plan has been announced.
Initiatives register (last 24 months)
| Date | Initiative | Type | Detail | Status |
|---|---|---|---|---|
| Oct 2024 | 10-to-1 share consolidation | Capital structure | Board lot unchanged at 2,000 shares | Completed 25 Oct 2024 |
| FY2025 | Share issuance (about HK$12 M) | Capital raising | Shares rose from 40 M to 60 M (post-consolidation) | Completed. |
| Mar 2025 | Share registrar change | Administration | To Union Registrars | Completed |
| May–Jun 2025 | Hope Life share disposals | Portfolio monetisation | About HK$24.9 M gross across three tranches (analyst sum of 7.85 + 8.49 + 8.51) | Completed |
| Aug 2025 | Type 2 licence ceased | Rationalisation | Dormant futures capability dropped | Completed |
| Sep 2025 – Mar 2026 | Disposal of Innovax Credit and Innovax Management | Divestiture | HK$58.2 M (subject to adjustment) | Completed 31 Mar 2026 |
| FY2026 | Exit from bond underwriting | Risk reduction | No bond deals versus 25 in FY2025 | Ongoing |
| FY2026 | Asset management scale-up | Growth | AUM more than tripled to HK$216.3 M | Ongoing |
| May–Aug 2026 | Rebrand to Austrax (name, logo, website, stock short name) | Repositioning | Effective 2 Jul and 10 Aug 2026 | Completed |
ESG commitments: no quantified targets disclosed.
Cost programmes: "disciplined cost control" is stated but carries no numerical target.
Medium-term financial targets or guidance: none publicly disclosed.
Products & Services
Pricing models are not publicly disclosed for any service line except money lending interest-rate ranges. "Launch year" refers to when the group first disclosed the activity.
Corporate Finance Advisory (Innovax Capital Limited)
5.1.1 IPO sponsorship
What it is: acting as sole or joint sponsor for listing applicants on the Main Board and GEM, covering due diligence, prospectus coordination and regulator liaison.
Capability: at least one sponsor principal (historically CEO Poon Siu Kuen) and Type 6 licence.
Target customers: small and mid-cap Hong Kong and PRC issuers.
Activity: 7 mandates in each of FY2025 and FY2026; no IPO completed as sponsor in FY2026; fee income HK$3.5 M in FY2026 (FY2025: HK$2.0 M).
Pricing: milestone-based mandate fees (industry norm); terms not disclosed.
Launch: core service since the group was founded in 2014.
Flagship deals: not publicly disclosed in sources reviewed.
5.1.2 Financial advisory
What it is: acting as financial adviser to listed companies and their major shareholders on notifiable and connected transactions under the Listing Rules and GEM Listing Rules, and to controllers and investors on Takeovers Code matters (offers, whitewash waivers, privatisations).
Activity: 21 mandates in FY2026 (FY2025: 23).
5.1.3 Independent financial advisory
What it is: acting as IFA to independent board committees and independent shareholders on connected transactions and takeover offers.
Activity: 8 mandates in FY2026 (FY2025: 6). Combined FA and IFA revenue was HK$4.8 M in FY2026 (FY2025: HK$4.5 M).
5.1.4 Compliance advisory
What it is: a post-listing compliance adviser role for newly listed and existing issuers (Main Board and GEM), typically a mandatory appointment running to the first full-year results after listing.
Activity: 9 mandates in FY2026 (FY2025: 9); revenue HK$1.6 M (FY2025: HK$2.0 M).
Placing and Underwriting (Innovax Securities Limited)
Three product types:
-
Placing agent, sub-placing agent, underwriter, sub-underwriter or distributor for new-share issues and placings of existing shares by listed companies.
-
Overall coordinator, bookrunner, lead manager, underwriter or distributor for IPOs.
-
Bookrunner, underwriter or sub-underwriter for bond issues by listed or unlisted corporations.
The group stopped bond underwriting in FY2026 because investors became more selective and demanded higher yields and stronger credit (Annual Report 2025/26).
Securities Dealing and Brokerage (Innovax Securities Limited)
What it is: agency brokerage for Hong Kong Main Board and GEM securities and US-listed securities.
Activity: 1,296 securities accounts at 28 Feb 2026 (FY2025: 1,003); commission income HK$5.3 M (FY2025: HK$2.9 M).
Planned extensions: discretionary account management, wealth management, and brokerage for US and other overseas markets.
Securities Financing (Innovax Securities Limited)
What it is: margin financing for secondary-market purchases and IPO financing for public-tranche subscriptions.
Activity: outstanding margin loans HK$19.3 M at 28 Feb 2026 (FY2025: HK$13.4 M); interest income HK$2.0 M (FY2025: HK$2.6 M).
Stance: management states a deliberately prudent, de-risking approach.
Research
Listed as a service in the Annual Report 2025/26. Scope, coverage universe and monetisation are not publicly disclosed. It is presumably bundled with brokerage under Type 4.
Asset Management (Innovax Asset Management Limited)
Products: 1. Fund management services to professional investors, through an SFC-registered open-ended fund company (OFC) structure in Hong Kong.
-
Innovax Alpha SPC, a segregated portfolio company managed under an investment management agreement disclosed as a fully exempt continuing connected transaction.
-
Discretionary account management.
Activity: AUM including investment funds rose to HK$216.3 M at 28 Feb 2026 from HK$69.2 M at 28 Feb 2025; fee income HK$3.7 M (FY2025: HK$0.5 M), up 661.8%.
Pipeline: multi-strategy and private equity funds, using the OFC, Cayman or limited partnership fund structures.
Key person: CIO Li Lap Sun (status after the change of control not publicly disclosed).
Money Lending (Innovax Credit Limited) — discontinued and disposed
| Metric | FY2025 | FY2026 |
|---|---|---|
| Number of personal loans | 10 | 11 |
| Outstanding personal loan principal (HK$ M) | 27.354 | 28.488 |
| Personal loan interest rate range (% p.a.) | 3–15 | 3–10 |
| Number of corporate loans | 1 | 2 |
| Outstanding corporate loan principal (HK$ M) | 2.443 | 4.077 |
| Corporate loan interest rate (% p.a.) | 5 | 5–10 |
| Loan receivables (HK$ M) | 29.8 | 32.6 |
| Largest borrower (% of loans) | 29.5 | 27.0 |
| Top five borrowers (% of loans) | 76.6 | 70.2 |
The business started around FY2022 and was disposed of on 31 March 2026. It included loans to directors Chung Chi Man and Poon Siu Kuen, which were disclosed as fully exempt connected transactions. No bad or doubtful debts were recorded in FY2026.
Futures Dealing (Innovax Futures Limited) — dormant
The group held a Type 2 licence from June 2019 to 14 August 2025 and generated no revenue from it. Management says it may reapply when timing is appropriate.
Product Portfolio
| Activity | FY2025 | FY2026 |
|---|---|---|
Number of transactions | 33 | 6 |
Of which bond issues by unlisted corporations | 25 | 0 |
FY2026 mix | — | 2 sub-placing or distributor roles on new-share issues; 1 placing of existing shares; 2 placings of new shares; 1 joint bookrunner and joint lead manager role on an IPO |
Revenue (HKD Mn) | 151.5 | 1.8 |
Financial Narrative
Basis: consolidated figures in HK$ M. The latest five fiscal years are FY2022 (year to 28 Feb 2022) through FY2026 (year to 28 Feb 2026). Standardised line items come from S&P Global Market Intelligence via StockAnalysis.com, cross-checked against company announcements where available (FY2022, FY2023, FY2025 and FY2026 headline revenue and profit agree with filings). FY2025 is shown as restated for discontinued operations in the income statement, except net income, which includes discontinued operations.
Income statement
Gross profit is not reported. The company presents a services income statement without cost of sales, so a gross profit line and gross margin are not meaningful and are omitted from the chart tables. The FY2025 sub-underwriting pass-through (HK$148.7 M within other operating expenses) is the closest thing to a cost of revenue.
Margins and growth (%; analyst calculations from 6.1, S&P revenue basis)
Revenue CAGR FY2022–FY2026 (S&P basis, 4 years): about -10.3% a year (analyst calculation: (22.58 / 34.86)^(1/4) - 1).
For context on earlier years, FY2021 revenue was about HK$83.95 M with net profit of about HK$2.38 M (TipRanks; not cross-checked to the FY2021 annual report). FY2020 net profit was HK$1.6 M and FY2019 was HK$12.3 M (FY2020 annual results announcement).
Commentary on the income statement.
-
No structural operating profitability. S&P-basis operating income was negative in every one of the five years. The best year was FY2025 (-HK$16.0 M), and only because the bond-underwriting gross-up inflated revenue. Without the pass-through, FY2025 core revenue was about HK$17 M (analyst calculation: 165.9 less 148.7 sub-underwriting cost), comparable to FY2026.
-
Staff costs were reset. They fell from about HK$41 M (FY2023–FY2024) to HK$22.2 M in FY2025, then rose 9.8% to HK$24.3 M in FY2026, which management attributes to more professional staff and a long-service-payment provision. Headcount was flat at 38.
-
Earnings are an investment-book outcome. The swing between net loss and net profit maps almost one-to-one onto investment gains: -8.4 (FY2022), +0.6, +22.4, -26.1 and +24.8 (FY2026). Management explains FY2026's HK$11.7 M profit as a net realised FVTPL gain of HK$29.1 M less a net unrealised loss of HK$1.8 M. That compares with FY2025's net unrealised loss of HK$16.3 M and net realised loss of HK$9.8 M.
-
Profit alert accuracy. The 19 May 2026 alert guided to HK$9–13 M; the actual result was HK$11.7 M, near the midpoint.
-
No dividends. None were declared for FY2022 to FY2026.
Balance sheet
Sources: S&P Global via StockAnalysis.com. FY2025 and FY2026 cash and net current assets match the Annual Report 2025/26 (net current assets HK$197.4 M and HK$184.6 M; cash and bank balances HK$108.7 M and HK$97.2 M). Book value per share for FY2022–FY2024 is on 40 M shares and for FY2025–FY2026 on 60 M shares.
Commentary on the balance sheet.
-
The group is debt-free apart from leases. Management reports a gearing ratio of nil and no bank loans at both FY2025 and FY2026 year ends, and no pledged assets, capital commitments or contingent liabilities.
-
Equity has been essentially static at about HK$187–210 M for five years. The roughly HK$12 M share issue in FY2025 only partly offset that year's HK$35.3 M loss.
-
The FY2025 balance-sheet expansion (total assets HK$353 M; payables HK$163 M) reflects year-end settlement balances tied to the bond underwriting activity. It unwound in FY2026.
-
The fall in trading securities from HK$44.2 M to HK$10.8 M in FY2026, alongside still-elevated "other current assets", is consistent with the Hope Life disposals and with Innovax Management's portfolio and the loan book being presented as a disposal group held for sale. This is an analyst inference.
-
After the 31 March 2026 completion, those assets were exchanged for consideration of about HK$58.2 M (subject to fair-value adjustment), with an estimated gain of about HK$3.8 M per the disposal circular. Settlement mechanics and the final adjusted consideration are not publicly disclosed in sources reviewed.
Cash flow
Source: S&P Global via StockAnalysis.com (updated 25 June 2026). The Annual Report 2025/26 confirms no share repurchases in FY2026 or up to the report date.
Commentary on cash flow. Operating cash flow is dominated by working-capital swings in client receivables and payables and by investment-book turnover, not by underlying profitability. Capex is negligible (asset-light, leased office). Cumulative FCF over five years was about +HK$15.2 M (analyst sum), against cumulative net losses of about HK$50.9 M. The gap reflects non-cash fair-value losses and working-capital release.
Ratios
All ratios are analyst calculations from 6.1 and 6.3. FY2025 and FY2026 current ratios agree with the company-reported 2.11x and 2.91x. FY2022–FY2024 current ratios are derived as (working capital + current liabilities) / current liabilities.
Ratios that are not meaningful or not computable:
ROIC: invested capital is negative once cash is netted, and operating income is negative.
Net debt / EBITDA: the group has net cash and negative EBITDA.
Interest coverage: the only interest expense is lease interest of HK$0.04–0.27 M and EBIT is negative.
Cash conversion cycle: not applicable to a broker and adviser with no inventory.
Inflections and drivers.
FY2023: a brief advisory recovery (revenue +29.8%).
FY2024: advisory and placing slump (revenue -27.8%), rescued by investment gains.
FY2025: bond-underwriting gross-up masked weak core activity while the investment book lost HK$26.1 M.
FY2026: core fee lines (advisory, brokerage, asset management) grew while underwriting collapsed. Profit came again from the investment book.
The return on equity has never exceeded 6% in the five-year window.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Role | Status |
|---|---|---|
Austrax Holdings Limited (Cayman) | Listed holding company | Active |
Crystal Prospect Limited | Intermediate holding company (seller under the disposal) | Active |
Innovax Capital Limited | Corporate finance (Type 1 and Type 6; sponsor-eligible); responsible officers formerly Chung Chi Man and Poon Siu Kuen | Active. Post-May 2026 responsible-officer roster not publicly disclosed |
Innovax Securities Limited | Brokerage, placing and underwriting, securities financing, research | Active |
Innovax Asset Management Limited | Type 9 asset management; investment manager to Innovax Alpha SPC | Active |
Innovax Futures Limited | Type 2 futures dealing; licensed June 2019 to 14 Aug 2025; never traded | Licence ceased. Entity status not publicly disclosed |
Innovax Credit Limited | Money lending (Money Lenders Ordinance) | Disposed to Maine Sky Limited on 31 Mar 2026 |
Innovax Management Limited | Investment holding (held listed securities such as Hope Life shares) | Disposed to Maine Sky Limited on 31 Mar 2026 |
Revenue by Segment and Segment Assets & Liabilities
| Service line (HKD Mn) | FY2025 | FY2026 |
|---|---|---|
Corporate finance advisory — IPO sponsorship | 2.0 | 3.5 |
Corporate finance advisory — financial and independent financial advisory | 4.5 | 4.8 |
Corporate finance advisory — compliance advisory | 2.0 | 1.6 |
Corporate finance advisory — subtotal | 8.5 | 9.9 |
Placing and underwriting | 151.5 | 1.8 |
Securities dealing and brokerage | 2.9 | 5.3 |
Securities financing (interest) | 2.6 | 2.0 |
Asset management | 0.5 | 3.7 |
Total revenue — continuing operations | 165.9 | 22.7 |
Money lending interest (discontinued operation) | 1.7 | 2.4 |
Segment Revenue
| Service line | YoY growth FY2026 (%) | Share of FY2025 continuing revenue (%) | Share of FY2026 continuing revenue (%) |
|---|---|---|---|
Corporate finance advisory | +16.1 (company-stated) | 5.1 | 43.6 |
Placing and underwriting | -98.8 | 91.3 | 7.9 |
Securities dealing and brokerage | +85.3 (company-stated) | 1.7 | 23.3 |
Securities financing | -23.1 | 1.6 | 8.8 |
Asset management | +661.8 (company-stated) | 0.3 | 16.3 |
Revenue type (HKD Mn, S&P Global classification)
| Revenue type (HKD Mn, S&P Global classification) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Underwriting and investment banking fees (corporate finance advisory plus placing and underwriting) | 19.03 | 26.98 | 22.65 | 159.96 | 11.64 |
Interest and dividend income | 13.47 | 14.97 | 6.65 | 2.61 | 2.00 |
Brokerage commission | 1.90 | 3.13 | 3.00 | 2.87 | 5.31 |
Asset management fees | 0.55 | 0.46 | 0.43 | 0.49 | 3.75 |
Total revenue (S&P basis) | 34.86 | 45.24 | 32.68 | 165.80 | 22.58 |
Revenue by Segment and Per-Share Data
| Metric (HKD Mn) | 1H FY2025 | 1H FY2026 |
|---|---|---|
Total revenue | 93.7 | 12.0 |
Profit (loss) for the period | -22.9 | 18.3 |
Net realised and unrealised FVTPL gain | — | 24.1 |
Basic EPS (HK cents) | -47.16 | 30.47 |
“—” = not publicly disclosed.
Income Statement and Per-Share Data
| Metric (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue — company-reported | 34.96 | 45.54 | 32.73 | 165.93 | 22.70 |
Revenue — S&P standardised | 34.86 | 45.24 | 32.68 | 165.80 | 22.58 |
Staff costs | 37.39 | 41.39 | 41.37 | 22.16 | 24.34 |
Other operating expenses | 9.72 | 12.65 | 15.06 | 158.35 | 17.47 |
Total operating expenses | 51.77 | 56.85 | 57.97 | 181.81 | 43.02 |
Operating income (S&P basis) | -16.91 | -11.61 | -25.29 | -16.01 | -20.43 |
Depreciation and amortisation | 3.68 | 2.81 | 1.55 | 1.30 | 1.21 |
EBITDA (operating income plus D&A, analyst calculation) | -13.23 | -8.80 | -23.74 | -14.71 | -19.22 |
Gain (loss) on investments (S&P) | -8.37 | 0.63 | 22.42 | -26.09 | 24.78 |
Pre-tax income (continuing operations) | -21.25 | -6.58 | 1.78 | -36.69 | 9.36 |
Income tax expense | 1.27 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit from discontinued operations | 0.00 | 0.00 | 0.00 | 1.41 | 2.35 |
Net income | -22.52 | -6.58 | 1.78 | -35.29 | 11.71 |
EPS basic (HK$, restated for 10:1 consolidation) | -0.56 | -0.16 | 0.04 | -0.69 | 0.20 |
EPS diluted (HKD) | -0.56 | -0.16 | 0.04 | -0.69 | 0.20 |
Dividends per share (HKD) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Margin Analysis (%)
| Metric (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue growth YoY | -58.47 | 29.77 | -27.75 | 407.29 | -86.38 |
Operating margin | -48.5 | -25.7 | -77.4 | -9.7 | -90.5 |
EBITDA margin | -38.0 | -19.5 | -72.6 | -8.9 | -85.1 |
Net margin | -64.6 | -14.5 | 5.4 | -21.3 | 51.9 |
Staff costs as % of revenue | 107.3 | 91.5 | 126.6 | 13.4 | 107.8 |
Balance Sheet and Per-Share Data
| Metric (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets | 303.34 | 307.62 | 283.60 | 353.03 | 302.77 |
Cash and bank balances | 58.83 | 87.39 | 112.02 | 97.20 | 108.67 |
Trading securities (FVTPL) | 42.32 | 42.59 | 69.52 | 44.15 | 10.75 |
Accounts receivable | 106.17 | 87.14 | 29.85 | 43.33 | 52.75 |
Other current assets (incl. held-for-sale disposal group in FY2026) | 82.37 | 70.72 | 48.93 | 133.24 | 127.84 |
Total debt (lease liabilities only) | 0.72 | 1.83 | 0.33 | 1.26 | 0.67 |
Short-term debt (current lease liabilities) | 0.72 | 1.50 | 0.33 | 1.01 | 0.59 |
Long-term debt (non-current lease liabilities) | 0.00 | 0.33 | 0.00 | 0.25 | 0.09 |
Net debt (debt minus cash; negative means net cash) | -58.11 | -85.56 | -111.69 | -95.94 | -108.00 |
Accounts payable (largely client-related) | 92.47 | 91.81 | 59.45 | 162.92 | 99.64 |
Total liabilities | 94.78 | 98.90 | 73.11 | 166.15 | 104.19 |
Shareholders' equity | 208.55 | 208.71 | 210.49 | 186.87 | 198.58 |
Goodwill and intangibles | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
Working capital (net current assets) | 205.80 | 200.74 | 208.98 | 184.58 | 197.37 |
Book value per share (HKD) | 5.21 | 5.22 | 5.26 | 3.11 | 3.31 |
Cash Flow
| Metric (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow | -6.89 | 30.05 | 22.74 | -29.32 | 8.96 |
Capital expenditure | 0.02 | 0.32 | 0.00 | 0.00 | 0.01 |
Free cash flow | -6.90 | 29.72 | 22.74 | -29.32 | 8.95 |
Lease payments | 2.30 | 1.64 | 1.50 | 1.15 | 1.26 |
Free cash flow after leases | -9.21 | 28.09 | 21.24 | -30.47 | 7.69 |
Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Proceeds from share issuance | 0.00 | 0.00 | 0.00 | 12.00 | 0.00 |
Net change in cash | -9.26 | 28.56 | 24.63 | -14.82 | 11.47 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%; net income / closing equity) | -10.80 | -3.15 | 0.85 | -18.88 | 5.90 |
ROA (%; net income / closing total assets) | -7.42 | -2.14 | 0.63 | -10.00 | 3.87 |
Current ratio (x) | 3.17 | 3.04 | 3.86 | 2.11 | 2.91 |
Debt / equity (%) | 0.35 | 0.88 | 0.16 | 0.67 | 0.34 |
Asset turnover (x; revenue / closing assets) | 0.115 | 0.147 | 0.115 | 0.470 | 0.075 |
Revenue by Region
| Region (HKD Mn) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Hong Kong — booking location of all group revenue (continuing operations) | 32.73 | 165.93 | 22.70 |
Growth metric (%)
| Growth metric (%) | FY2025 | FY2026 |
|---|---|---|
Hong Kong-booked revenue growth | 407.0 | -86.3 |
Share Price History
| Date | Price (HKD) | Market cap (HKD Mn) | Source |
|---|---|---|---|
Mar 2025 | about 1.21 (implied) | 72.6 | TipRanks (registrar-change article) |
May 2025 | about 1.86 (implied) | 111.6 | TipRanks (board meeting article) |
Late Jun 2025 | about 2.15 (implied) | 129.0 | TipRanks (Hope Life article) |
Apr 2026 | 6.00 (offer price) | 360.0 (at offer price) | Composite document |
16 Jul 2026 | 7.00 | 408.0 | StockAnalysis.com |
18 Aug 2026 | 6.60 | 396.0 | StockAnalysis.com |
9 Oct 2026 | 5.61 | 336.6 | StockAnalysis.com (delayed) |
Valuation Multiples
| Multiple | Austrax |
|---|---|
P/E (trailing, FY2026 EPS HK$0.20) | about 28.7x (aggregators show 32–44x depending on price date) |
P/B (FY2026 BVPS HK$3.31) | about 1.70x |
EV / Sales (EV about HK$228.6 M = 336.6 market cap - 108.67 cash + 0.67 leases) | about 10.1x |
EV / EBITDA | Not meaningful (negative EBITDA) |
Price / tangible book | about 1.70x |
Capital Markets
| Metric (HK$ per share) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share declared | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analyst Conclusions
Management guidance
Quantitative guidance: none. The Annual Report 2025/26 outlook is "cautiously constructive". It points to slower-than-expected Fed easing, geopolitical and trade risks, AI-driven growth, and Hong Kong's 3.5% real GDP growth in 2025, and it commits to prudent risk and cost management alongside strengthening the core business.
The new board: has articulated a corporate finance advisory focus for Hong Kong and Greater China, but with no targets.
Consensus
None available: no analyst coverage.
Bull case
-
Option value of a clean, licensed platform under an ambitious owner. The controller paid HK$270 M (HK$6.00 per share; 1.81x FY2026 book) and has installed a board with global investment banking pedigree. That points to intent to scale the business, possibly by injecting mandates or businesses, using a debt-free platform with about HK$108.7 M of cash plus disposal proceeds.
-
Operating leverage to a Hong Kong ECM upcycle. IPO fund-raising rose about 225% in 2025 and turnover about 162%. Brokerage (+85%), advisory (+16%) and asset management (+662%) already grew in FY2026. Seven live sponsorship mandates could convert into completed listings and placing fees.
-
Simplified, de-risked perimeter. The concentrated money lending book and the investment-holding vehicle have gone to the former owner, and bond underwriting has stopped. Future earnings should reflect fee franchises more cleanly.
Bear case
-
The core franchise does not earn its keep. Five straight years of negative operating income (-HK$20.4 M in FY2026). The investment-gain cushion that produced FY2026's profit is now partly gone with Innovax Management, and new executive pay adds about HK$3.6 M a year of fixed cost.
-
Human-capital flight. The CEO and sponsor principal and the founder-RO left on 30 May 2026. The status of the CIO, the head of ECM and the COO is undisclosed. In a sponsor business, people are the franchise and the licence conditions.
-
Governance and minority risk. A 75.07% controller who is also Chairman and CEO, alongside his father as the other executive director. A public float near the floor. A history of connected transactions. Minorities could be exposed to related-party deals, dilution or a low-premium privatisation.
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst or monitorable |
|---|---|
| 30 Oct 2026 | 1H FY2027 interims: first period without money lending and Innovax Management, and first under the new board. Watch fee revenue run-rate, the cost base and any disposal gain (about HK$3.8 M estimated) |
| 2H 2026 | Disclosure of new responsible officers and sponsor principals at Innovax Capital; any renaming of subsidiaries |
| Ongoing | Completed IPO sponsorships out of the 7 live mandates |
| Ongoing | Public float compliance and any placing to rebuild free float |
| Ongoing | Any asset injection, acquisition, fund-raising or connected transaction involving the controller's interests (e.g., Golden Hen Investment Management relationships) |
| Ongoing | AUM trajectory (HK$216.3 M base) and new fund launches |
| May 2027 | FY2027 annual results; dividend policy under the new owner |
Analyst verdict
Austrax Holdings, formerly Innovax Holdings, is best understood as a licensed shell in transition, not as an operating growth company. Over five fiscal years the business produced S&P-basis operating losses every year and a cumulative net loss of roughly HK$50.9 M. Its two profitable years were rescued by gains on a proprietary investment book. The headline FY2025 revenue of HK$167.7 M was mostly pass-through bond underwriting that left about HK$2.8 M of economic margin. The FY2026 profit of HK$11.7 M was produced by a HK$29.1 M realised investment gain set against a HK$22.7 M revenue base.
What changed in 2026 is ownership, not economics. Mr. Wang Tingfa paid HK$270 M for 75%, an unambiguous signal that he values the SFC licence stack, sponsor eligibility and listed status well above book. He has removed the founder's lending and investment vehicles, replaced the entire board with credible independent directors, and rebranded the group around Greater China corporate finance. Those moves create real option value. In the same stroke, however, the platform lost the two individuals who built and ran its sponsor business, and the new owner's operating plan, capital allocation intentions and senior hires remain undisclosed.
At about HK$5.61 the shares trade at about 1.7x book and about 10x EV to sales, slightly below the HK$6.00 control price, with negligible liquidity and no research coverage. That price embeds an expectation that the controller will inject business or scale origination materially. Nothing filed so far substantiates this.
Our stance is neutral-to-cautious with a speculative skew. The 1H FY2027 interims on 30 October 2026 and any disclosure of the rebuilt licensed management team are the decisive near-term tests. Absent evidence of new mandates or a funded growth plan by FY2027 results, the downside case (sub-scale losses, governance concentration, thin float) should dominate.
End of dossier. All figures in HK$ for fiscal years ending in February unless stated.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Appointed | Age (at 29 May 2026) | Background and education | Contracted remuneration |
|---|---|---|---|---|---|
Wang Tingfa (王庭發) | Chairman, CEO, executive director; controlling shareholder | 30 May 2026 | 39 | Investment director and fund manager at Beijing Beiao High-tech Investment Management Co., Ltd. (2017–2023). Director of Golden Hen Investment Management Limited, an SFC Type 4 and Type 9 licensed corporation (Apr 2023 – Oct 2025). BEng in Safety Engineering (South China University of Technology); Master's in Information and Operations Management (National Taipei University of Technology) | HK$1,800,000 a year plus discretionary bonus; 3-year term |
Wang Zhenyuan (王振元) | Executive director | 30 May 2026 | 66 | Father of Wang Tingfa. Marketing director of Golden Hen Investment Management (Jul 2023 – Oct 2025). Previously legal representative or person-in-charge of several sales offices of PRC power-equipment manufacturers (Northeast Power Transmission and Transformation Equipment; Jinzhou Switch Factory; Shenyang Transformer). Four of those entities had business licences revoked between 2003 and 2012; the company attributes this to missed annual inspections after they stopped operating, not fraud. Graduated from Fujian Province Yong'an No. 2 Middle School | HK$1,800,000 a year plus discretionary bonus; 3-year term |
Li Changqing (李常青) | INED; Chairman of Audit Committee | 30 May 2026 | 58 | Chinese CPA. Professor and doctoral supervisor at Xiamen University School of Management; Director of its EMBA Centre. Independent director of Bank of Hangzhou (600926.SH) since July 2023. Formerly independent director of Zijin Mining (2019–2025), Foryou Corporation and Shenzhen Noposion Crop Science. Doctor of Management (Accounting), Xiamen University | HK$130,000 base plus committee fees |
Li Yi (李一) | INED; Chairman of Remuneration Committee | 30 May 2026 | 65 | Chairman of New Times Corporation. Former CEO of Sino Biopharmaceutical; former Vice Chairman of Global Banking and Chairman and CEO of China at JPMorgan Chase; former Chairman and President of China at UBS Group and Chairman of UBS Securities; former General Manager of China Merchants Port Holdings. Former member of the 12th and 13th CPPCC National Committees. Wharton MBA | HK$130,000 base plus committee fees |
Ling Taotao (凌濤濤) | INED; Chairman of Nomination Committee | 30 May 2026 | 45 | Partner and General Counsel of Micro Connect. Previously led legal and compliance at investment companies and asset managers, and practised at UK and US law firms. LLB and BEcon (Peking University); LLM (NYU). Admitted in Hong Kong and New York | HK$130,000 base plus committee fees |
Directors' Remuneration
| Committee | Chair | Members |
|---|---|---|
Audit | Li Changqing | Li Yi; Ling Taotao |
Remuneration | Li Yi | Li Changqing; Ling Taotao |
Nomination | Ling Taotao | Li Yi; Li Changqing |
Executive Leadership Team
| Name | Role | Age | Prior experience | Post-change status |
|---|---|---|---|---|
Chau Lok Yi | CFO and Company Secretary | 46 | Morison Heng CPA (senior audit manager); Oriental Patron Securities; HKICPA practising certificate | Confirmed as company secretary and process agent (announcement of 7 Aug 2026) |
Li Lap Sun | CIO and executive director, Innovax Asset Management (since Mar 2017) | 59 | Merrill Lynch (1994–2004, director); Goldman Sachs (2004–2007, executive director); Spitzer Asset Management (2007–2017) | — |
Chau Lok Yuen, Amy | Head of Securities and Head of ECM; director of Innovax Securities | 49 | Sun Hung Kai Financial; China Everbright Securities International (ECM director) | — |
Lam King Fung | COO and Head of Compliance (since 2018) | 44 | China Everbright Securities International (SVP, legal and compliance) | — |
“—” = not publicly disclosed.
Board of Directors — Chung Chi Man
| Name | Former role | Tenure | Notes |
|---|---|---|---|
Chung Chi Man | Founder, Chairman, executive director | 2014 – 30 May 2026 | Age 53; CUHK BBA (1995); Sir Edward Youde Memorial Scholar; FCCA. Responsible officer (Type 1/6) of Innovax Capital. Bought back the money lending and investment subsidiaries via Maine Sky Limited |
Poon Siu Kuen, Calvin | CEO, executive director, sponsor principal | Joined Feb 2015 – 30 May 2026 | Age 55; KPMG; Kingsway Capital; China Everbright Capital (executive director, corporate finance); Monash University |
Wu Kwun Hing | INED (Nomination Committee chair) | 24 Aug 2018 – 30 May 2026 (Innovax Capital board since 2015) | More than nine years' service; re-elected by separate resolution at the 8 Aug 2025 AGM |
Chan Ka Lai, Vanessa | INED (Audit Committee chair) | 24 Aug 2018 – 30 May 2026 | FCPA; INED of several other Hong Kong-listed issuers |
Kwong Hon Nan, Eric | INED (Remuneration Committee chair) | 1 Nov 2024 – 30 May 2026 | Actuary (FSA, FASHK), CFA |
Directors' Remuneration (Annual)
| Metric | FY2026 |
|---|---|
Total directors' remuneration (HKD Mn) | 3.0 (FY2025: 3.0) |
Senior management including executive directors earning HK$0–1,000,000 | 4 individuals |
Senior management including executive directors earning HK$1,000,001–2,000,000 | 2 individuals |
Share options granted under the 2023 scheme | None since adoption |
Major Shareholders
| Holder | Shares | % of issued capital | Source |
|---|---|---|---|
Billion Shine International Investment Limited (100% owned by Wang Tingfa since 31 Mar 2026) | 45,000,000 | 75.00 | Offer closing announcement, 29 Apr 2026 |
Wang Tingfa (direct, via offer acceptances) | 39,825 | 0.07 | Offer closing announcement |
Public shareholders | about 14,960,175 | about 24.93 | Analyst calculation at offer close |
Competitive Landscape
Key Competitors
| Peer (HKEX code) | Overlap with Austrax | Relative positioning (qualitative) |
|---|---|---|
CL Group (Holdings) Ltd (8098) | Brokerage, placing and underwriting, margin finance | Similar micro-cap scale; named by TipRanks as a peer |
Value Convergence Holdings Ltd (821) | Brokerage, corporate finance, asset management | Similar small-cap profile; named by TipRanks as a peer |
Excalibur Global Financial Holdings Ltd (8350) | Brokerage and financial services | Micro-cap peer named by TipRanks |
Emperor Capital Group Ltd (717) | Brokerage, margin finance, placing and underwriting, corporate finance | Larger balance sheet and margin book |
Get Nice Holdings Ltd (64) | Brokerage, margin finance, underwriting | Larger margin-financing franchise |
Bright Smart Securities & Commodities Group (1428) | Retail brokerage and margin finance | Much larger retail brokerage platform |
First Shanghai Investments Ltd (227) | Brokerage, corporate finance, asset management | Diversified, larger |
CMBC Capital Holdings Ltd (1141) | ECM underwriting, bond underwriting, brokerage | Bank-backed; overlaps strongly with Austrax's former bond activity |
China Renaissance Holdings (1911) | Investment banking (advisory, ECM) | Upper-mid-market; far larger brand |
Unlisted sponsor boutiques (e.g., Somerley, Altus, Grande and similar) | IFA and FA mandates | Strong incumbent IFA franchises (qualitative; no data verified) |
Competitor Detail
| Metric | Austrax (FY2026) |
|---|---|
Revenue (HKD Mn) | 22.7 |
Revenue growth (%) | -86.3 |
Operating margin (%, S&P basis) | -90.5 |
Net margin (%) | 51.9 (investment-gain driven) |
R&D intensity (%) | not disclosed (not applicable) |
ROE (%) | 5.9 |
Market cap (HKD Mn, about 9 Oct 2026) | 336.6 |



